4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.
- SEC Form 4 filed by Director Detheux Michel
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Namouni Fouad
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Joustra Wouter
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Kalir Erez
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- Director Unterseher Loren A was granted 4,304 shares, increasing direct ownership by 18% to 28,017 units (SEC Form 4)
4 - SkyWater Technology, Inc (0001819974) (Issuer)
- SEC Form 4 filed by Director Cumbo Alexander
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Beckman Daniella
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Levin Andrew David
4 - Vor Biopharma Inc. (0001817229) (Issuer)
- SEC Form 4 filed by Director Donenberg Phillip B.
4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Holmen Bob
4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Director Ra Capital Management, L.P. was granted 5,500 shares (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)
- Director Sutil Vicky was granted 3,436 shares, increasing direct ownership by 12% to 32,804 units (SEC Form 4)
4 - Delek US Holdings, Inc. (0001694426) (Issuer)
- Director Finnerty William J was granted 3,436 shares, increasing direct ownership by 9% to 39,805 units (SEC Form 4)
4 - Delek US Holdings, Inc. (0001694426) (Issuer)